STAAR SURGICAL CO
Financial highlights
| Metric | FY January 2, 2026 | FY December 27, 2024 | FY December 29, 2023 | FY December 30, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $239.4M | $313.9M | $322.4M | $239.4M | $230.5M |
| Gross profit | $182.4M | $239.6M | $252.7M | $223.4M | $178.6M |
| Operating income | -$91.7M | -$12.6M | $28.1M | $43.8M | $33.3M |
| Cost of revenue | $57.0M | $74.3M | $69.8M | $61.0M | $51.8M |
| Cash from operations | -$34.2M | $15.7M | $14.6M | $35.7M | $44.0M |
| Capital expenditure | $5.8M | $23.4M | $18.2M | $18.1M | $13.6M |
| Free cash flow | -$40.0M | -$7.7M | -$3.6M | $17.6M | $30.3M |
| Share repurchases | $6.5M | — | — | — | — |
| Impairments | — | — | $154,000 | — | — |
| Total assets | $451.7M | $509.5M | $488.7M | $418.8M | $345.8M |
| Total liabilities | $107.5M | $112.2M | $102.7M | $82.7M | $87.2M |
Shares outstanding 49.5M · Free float 33.8%
Annual filing data through FY ended January 2, 2026; float as of July 8, 2026.